Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice.
about
Progresses towards safe and efficient gene therapy vectorsAAV2/8-humanFOXP3 gene therapy shows robust anti-atherosclerosis efficacy in LDLR-KO mice on high cholesterol dietAAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet.Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways.
P2860
Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@ast
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@en
type
label
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@ast
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@en
prefLabel
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@ast
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@en
P2093
P2860
P1433
P1476
Comparison of efficacy of the ...... ivery in atherosclerotic mice.
@en
P2093
Everardo Cobos
Hongqing Zhu
Jose A Figueroa
Leonardo Mirandola
Maohua Cao
Maurizio Chiriva-Internati
Paul L Hermonat
P2860
P304
P356
10.1371/JOURNAL.PONE.0094665
P407
P577
2014-04-15T00:00:00Z